RMD Open (Jul 2023)

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study

  • Jérémie Sellam,
  • Laurent Arnaud,
  • Marta Mosca,
  • Florenzo Iannone,
  • Luca Diamanti,
  • Luca Iaccarino,
  • Aurélien Guffroy,
  • Jacques-Eric Gottenberg,
  • Veronica Codullo,
  • Alain Meyer,
  • Simone Barsotti,
  • Jelena Blagojevic,
  • Lorenzo Cavagna,
  • François Séverac,
  • Bernard Geny,
  • Jean Sibilia,
  • Marie Hudson,
  • François Maurier,
  • Benjamin Terrier,
  • Silvia Bellando-Randone,
  • Emanuelle Dernis,
  • Carlotta Nannini,
  • Marion Couderc,
  • Anne Tournadre,
  • Jean Jacques Dubost,
  • Albert Selva-O'Callaghan,
  • Claire de Moreuil,
  • Giacomo Emmi,
  • Baptiste Hervier,
  • Guilhem Sole,
  • Philippe Guilpain,
  • Jean-François Viallard,
  • Aleksandra Nadaj-Pakleza,
  • Enrico Marchioni,
  • Monica Groza,
  • Sergio Prieto-González,
  • Nicolas Poursac,
  • Isabelle Guichard,
  • Kubéraka Mariampillai,
  • Yves Troyanov,
  • Luc Pijnenburg,
  • Antoine Soulages,
  • Jean-Marc Galempoix,
  • Margherita Giannini,
  • Maude Bouchard-Marmen,
  • Livio Bernardi,
  • Paola Bini,
  • Fanny Duval,
  • Delphine Lebrun,
  • Jean-Maxime Piot,
  • Eglantine Rouanet,
  • Nathalie Vernier,
  • Veronique Vesperini,
  • Rahima Ziane

DOI
https://doi.org/10.1136/rmdopen-2023-003081
Journal volume & issue
Vol. 9, no. 3

Abstract

Read online

Background Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM).Objectives To assess the significance of DH/BS in patients with IM.Methods Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1.Results 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p<0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p<0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p<0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p<0.05).Conclusion In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).